Use the fields below to perform an advanced search of The Chronicle's archives. This will return articles, images, and multimedia relevant to your query. You can also try a Basic search
104 items found for your search. If no results were found please broaden your search.
As Thanksgiving slowly approaches, bringing family reunions and turkey dinners as well as exams and term papers, health is the last thing on many students' minds. But health professionals warn that November is the time for students to get flu shots to ward off sickness during the coming winter months.
Eric Wieschaus, Nobel Laureate and professor of molecular biology at Princeton University, discussed the clinical applications of basic science research before a standing-room only crowd Friday afternoon.
When John Glenn flies into space at two o'clock this afternoon, he will be more than a single man on a mission to outer space. Rather, his roles as an American hero, U.S. senator, senior citizen and scientific subject have once again thrust him into the spotlight and brought generations together in awe of his accomplishments: His mission will prompt older generations to reminisce about his orbit around the Earth 36 years ago and younger generations to become acquainted with the wonder of space flight.
Nobel Laureate Eric Wieschaus, a biology professor at Princeton University, will speak this Friday at 3:45 in Room 103 of the Bryan Research building. His speech is part of Friday's Graduate Student Symposium in the Biological Sciences, which will also highlight a variety of graduate students' works.
Although research moves slower than women with breast and ovarian cancer might hope, University researchers plan to begin a phase II clinical trial by the end of the year of a vaccine they hope will prevent the recurrence of these cancers in up to one third of women already afflicted.
This story is the last in a three-part series examining integrative medicine.
Women in their 40s who undergo mammography screenings to detect breast cancer seldom benefit from such tests, and many may suffer emotional and physical damage from the consequences of incorrect results, according to a study by a Duke professor published today in the Journal of the National Cancer Institute.
"Genetics is going to transform medicine's ability to not only cure disease, but prevent it before it comes," said Dr. Ralph Snyderman, chancellor for health affairs, at a genetics symposium this weekend. The symposium was part of the kickoff weekend for the public phase of the Campaign for Duke.
Dr. Edward Holmes will become the Medical Center's new vice chancellor for academic affairs and dean of medical education at the School of Medicine in 1999, Chancellor for Health Affairs Dr. Ralph Snyderman announced Wednesday. Holmes will fill the spot currently occupied by outgoing vice chancellor Dr. Gordon Hammes, professor of biochemistry.
The National Cancer Institute has awarded the University about $3.7 million to establish a cancer genetics research consortium involving researchers from Duke, the University of North Carolina at Chapel Hill and Emory University. The Medical Center News Office announced last Thursday that the new center will join eight similar facilities nationwide to establish a comprehensive database on the genetics basis of cancer development.
As doctors and staff at Raleigh Community Hospital went about the daily business of treating patients last Wednesday, they hardly noticed the changes in management. But the transition gives those employees a very different employer.
"I just feel like it's a little bit-at least on my part-that I can do to help out," said Rhonda Rogers. A senior medical technologist in molecular pathology, she has visited the American Red Cross blood drive site in the Duke Clinic every 56 days for the past year. "It makes me feel good."
Duke University Health System has officially added another piece to its ever-growing health-care puzzle.
Based on the results recently compiled from a study of diabetic mice, humans who are genetically predisposed to type II diabetes may be able to counteract the effects of the disease by eating a diet low in fat, claimed University professor of psychology and health sciences Dr. Richard Surwit in this month's issue of Metabolism.
At the end of every summer, first-year students at the School of Medicine prepare themselves for a strenuous year of gross anatomy, biochemistry and other new challenges. This year's 98-person class, however, bears a slightly different face.
Athletes are injury-prone, and not just when they're trying to generate sympathy from referees during the World Cup. But now, thanks to the Michael W. Krzyzewski Human Performance Laboratory, every athlete-from the casual weekend warriors to the stars of the men's basketball team-will have a new helping hand when injury strikes.
Using their own findings as stepping stones, medical researchers have made one more stride toward alleviating the deadly effects of head and neck cancers.
When she was three years old, Angela Bates was diagnosed with sickle cell disease, an affliction that has caused her physical pain and emotional trauma. But when the 32-year-old Tennessee native moved to North Carolina in 1994, she found the Duke-University of North Carolina Comprehensive Sickle Cell Center, a discovery which helped her become virtually pain-free.
The male impotence drug Viagra has found a place in national headlines and comedy skits since its approval by the Food and Drug Administration late last March. In addition to offering many impotent men the chance for normal sexual intercourse, however, its release has renewed debate about insurance coverage of fertility options for both men and women.
Complete with golden tickets, the Comprehensive Cancer Center's celebration of National Cancer Survivors' Day honored patients and their families with a "Willy Wonka and the Chocolate Factory" celebration. The day culminated with a viewing of the 1971 movie starring Gene Wilder.
